Skip to main content

James Topper

Equibles does not estimate personal net worth.

Get an email with a short summary when Phathom Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.

Get PHAT alerts

About James Topper

James Topper is recorded as Board Member at Phathom Pharmaceuticals, Inc. (PHAT). The newest filing on record that lists James Topper as Board Member at Phathom Pharmaceuticals, Inc. (PHAT) is dated April 7, 2026. Earlier roles on record: Chairman and Board Member at Anaptysbio, Inc (ANAB) until September 15, 2023. Anaptysbio, Inc reported in an 8-K filed September 18, 2023 that James Topper resigned as Class II director, effective September 15, 2023. Anaptysbio, Inc reported in an 8-K filed September 18, 2023 that James Topper resigned as Chairman of the Board, effective September 15, 2023. Phathom Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Phathom Pharmaceuticals, Inc. includes Steven Basta (CEO and Board Member), Steven L. Basta (CEO and Board Member), Anthony Guzzo (CFO and Chief Accounting Officer) and 7 others.

“On September 14, 2023, James N. Topper, M.D., Ph.D., advised the Board of Directors (the "Board") of AnaptysBio, Inc. (the "Company") that he would resign as a Class II director and as Chairman of the Board, effective on September 15, 2023.”
Anaptysbio, Inc Form 8-K, filed September 18, 2023 · Read the filing
“On September 14, 2023, James N. Topper, M.D., Ph.D., advised the Board of Directors (the "Board") of AnaptysBio, Inc. (the "Company") that he would resign as a Class II director and as Chairman of the Board, effective on September 15, 2023.”
Anaptysbio, Inc Form 8-K, filed September 18, 2023 · Read the filing

Affiliation history

Company network

Biotechnology · Healthcare

Chairman, Board Member

2022-04-25–2023-09-15

Leadership on record at Phathom Pharmaceuticals, Inc.

Recent activity